Literature DB >> 16710500

Ethambutol-associated optic neuropathy.

Su-Ann Lim1.   

Abstract

INTRODUCTION: Ethambutol is used in the treatment of tuberculosis, which is still prevalent in Southeast Asia, and can be associated with permanent visual loss. We report 3 cases which presented with bitemporal hemianopia. CLINICAL PICTURE: Three patients with ethambutol-associated toxic optic neuropathy are described. All 3 patients had loss of central visual acuity, colour vision (Ishihara) and visual field. The visual field loss had a bitemporal flavour, suggesting involvement of the optic chiasm. TREATMENT: Despite stopping ethambutol on diagnosis, visual function continued to deteriorate for a few months. Subsequent improvement was mild in 2 cases. In the third case, visual acuity and colour vision normalised but the optic discs were pale. OUTCOME: All 3 patients had some permanent loss of visual function.
CONCLUSIONS: Ethambutol usage is associated with permanent visual loss and should be avoided if possible or used with caution and proper ophthalmological follow-up. The author postulates that in cases of ethambutol associated chiasmopathy, ethambutol may initially affect the optic nerves and subsequently progress to involve the optic chiasm.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710500

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  12 in total

1.  Risk factors for ethambutol optic toxicity.

Authors:  Katherine Anne Talbert Estlin; Alfredo A Sadun
Journal:  Int Ophthalmol       Date:  2009-02-11       Impact factor: 2.031

2.  Trauma-Associated Leber Hereditary Optic Neuropathy.

Authors:  Supanut Apinyawasisuk; Jane W Chan; Anthony C Arnold
Journal:  Neuroophthalmology       Date:  2016-05-26

3.  Sibling Ethambutol Optic Chiasmopathy.

Authors:  Viran Jayanetti; Michael Rossiter-Thornton; Domit Azar; Clare L Fraser
Journal:  Neuroophthalmology       Date:  2017-05-30

4.  Gene expression and histopathological evaluation of thiamine pyrophosphate on optic neuropathy induced with ethambutol in rats.

Authors:  Emine Cinici; Nihal Cetin; Bahadir Suleyman; Durdu Altuner; Oguzhan Yarali; Hilal Balta; Ilknur Calik; Levent Tumkaya; Halis Suleyman
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

5.  Structural impairment patterns in peripapillary retinal fiber layer and retinal ganglion cell layer in mitochondrial optic neuropathies.

Authors:  Da Teng; Chun-Xia Peng; Hai-Yan Qian; Li Li; Wei Wang; Jun-Qing Wang; Bing Chen; Huan-Fen Zhou; Shi-Hui Wei
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

6.  A 37-year-old woman presenting with impaired visual function during antituberculosis drug therapy: a case report.

Authors:  Abdulkabir A Ayanniyi; Rashidat O Ayanniyi
Journal:  J Med Case Rep       Date:  2011-07-19

Review 7.  The rare ethambutol-induced optic neuropathy: A case-report and literature review.

Authors:  Wei Song; Shancheng Si
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  A review of drug isomerism and its significance.

Authors:  Naveen Chhabra; Madan L Aseri; Deepak Padmanabhan
Journal:  Int J Appl Basic Med Res       Date:  2013-01

9.  Chemotherapeutic interventions against tuberculosis.

Authors:  Neeraj Shakya; Gaurav Garg; Babita Agrawal; Rakesh Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-28

10.  Macular thickness as a predictor of loss of visual sensitivity in ethambutol-induced optic neuropathy.

Authors:  Chun-Xia Peng; Ai-di Zhang; Bing Chen; Bing-Jian Yang; Qiu-Hong Wang; Mo Yang; Shi-Hui Wei
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.